Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over the toll of OxyContin - On Thursday, Purdue Pharma ...

Purdue Pharma and the Sackler family members who own the company have agreed to pay up to $7.4 billion in a new settlement to ...

This story incorporates reporting fromBoston.com, Philadelphia Inquirer, The Boston Globe, pharmaphorum, Hartford Courant, ...

Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the ...

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and ...

The deal represents an increase over a previous settlement rejected by the Supreme Court because it protected members of the ...

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running ...

The Sackler family and Purdue Pharma, maker of OxyContin, have increased their settlement offer to $7.4 billion amid ongoing ...

State AGs have reached a new opioid settlement worth $7.4 billion with Purdue Pharma and its owners. The settlement does not ...

The settlement is the largest deal to date with the people primarily who played an “instrumental role” in driving the opioid ...

The Sackler family agreed to give up ownership of the company that manufactures the powerful opioid. A previous deal was ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...